Law & Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law & Health Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Allos Therapeutics, Inc.

Allos Therapeutics reports loss of $0.10 per share

For the 3 months ended December 31, 2005, the company reported a net loss of $5.3 million, or $0.10 per share. This compares to a net loss of $5.0 million, or $0.16 per share, for the fourth quarter of 2004.

For the year ended December 31, 2005, the company reported a net loss attributable to common stockholders of $20.8 million, or $0.45 per share, compared to a net loss of $21.8 million, or $0.70 per share, for 2004.

Cash, cash equivalents, and investments in marketable securities as of December 31, 2005 totaled $55.3...

• View Other Issues of Law & Health Weekly
  
• View Other NewsRx Publications